Paul Stoffels

CEO & Chairman at Galapagos

Speaker

Dr. Paul Stoffels is a visionary leader who inspires and drives transformational innovation to bring years of life and quality of life to millions of people around the world. As Chief Executive Officer1 and Chairman of biopharmaceutical company Galapagos, his mission is to help people live longer and better lives, focusing on adding years of life and quality of life. Previously, Paul was Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson where he led teams across the organization to set the company-wide innovation agenda, discovering and developing transformational healthcare solutions. Prior to that, he was Worldwide Chairman of Pharmaceuticals for Johnson & Johnson, where he significantly rejuvenated the product pipeline and implemented a transformational R&D operating model, resulting in the global launch of 25 innovative medicines, including 10 in oncology. Paul joined Johnson & Johnson in 2002, with the acquisition of Virco and Tibotec, where he was respectively CEO and Chairman and led the development of several breakthrough products for the treatment of HIV. Paul was a member of the Board of Directors of Galapagos NV from its incorporation until 2002. He is currently a member of the Supervisory Board of Philips Healthcare in the Netherlands